PDT Partners’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$759K Sell
57,438
-95,940
-63% -$1.14M 0.04% 358
2026
Q1
$1.44M Buy
+153,378
New +$1.37M 0.09% 284
2024
Q4
Sell
-63,657
Closed -$856K 725
2024
Q3
$856K Buy
+63,657
New +$938K 0.08% 401
2024
Q2
Sell
-21,937
Closed -$411K 671
2024
Q1
$411K Sell
21,937
-51,941
-70% -$1.04M 0.04% 487
2023
Q4
$1.67M Buy
73,878
+34,963
+90% +$758K 0.18% 193
2023
Q3
$965K Buy
+38,915
New +$979K 0.12% 295
2022
Q2
Sell
-23,810
Closed -$516K 974
2022
Q1
$516K Buy
23,810
+15,365
+182% +$333K 0.04% 573
2021
Q4
$234K Buy
+8,445
New +$205K 0.02% 737
2019
Q1
Sell
-30,128
Closed -$221K 447
2018
Q4
$221K Buy
30,128
+5,081
+20% +$42.6K 0.01% 393
2018
Q3
$219K Buy
+25,047
New +$256K 0.01% 424
2015
Q4
Sell
-43,021
Closed -$586K 482
2015
Q3
$586K Buy
+43,021
New +$584K 0.01% 866
2014
Q2
Sell
-34,933
Closed -$282K 1426
2014
Q1
$282K Buy
+34,933
New +$344K 0.01% 1137

Other funds holding CCRN

PDT Partners's CCRN Position: Q2 2026 in Review

PDT Partners reduced its Cross Country Healthcare (CCRN) stake by 63% in Q2 2026, selling an estimated $1.14M and leaving 57,438 shares worth $759K. The position accounts for 0.04% of the portfolio, ranked #358.

PDT Partners first reported a position in CCRN in Q1 2014 and has held it in 12 quarters since. The position peaked at $1.67M in Q4 2023. 151 funds tracked by Wall St. Rank hold CCRN as of Q2 2026.

  • PDT Partners held 57,438 shares of Cross Country Healthcare worth $759K as of Q2 2026.
  • PDT Partners sold 95,940 Cross Country Healthcare shares in Q2 2026, an estimated $1.14M.
  • Cross Country Healthcare made up 0.04% of PDT Partners's portfolio in Q2 2026, its #358 holding.
  • PDT Partners first reported a position in Cross Country Healthcare in Q1 2014 and has held it in 12 quarters since.
  • PDT Partners's Cross Country Healthcare position peaked at $1.67M in Q4 2023.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2026.

Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.